Application of The FODMAP Diet in a Paediatric Setting

Nutrients. 2022 Oct 18;14(20):4369. doi: 10.3390/nu14204369.

Abstract

In adults, dietary management, particularly with the FODMAP diet, is a key evidence-based part of multimodal therapy for patients with disorders of the gut-brain interaction, particularly irritable bowel syndrome. This review aims to describe the evidence for the use of this diet and how to deliver it in paediatric practice. A literature review covering studies on the FODMAP diet in adult and paediatric settings was conducted. While the evidence for the efficacy and safety of a FODMAP diet delivered in three phases, restriction, rechallenge and personalisation, is considerable, there is a lack of good-quality clinical trials exploring the efficacy of the diet in children and adolescents. Likewise, there are limited data on safety concerns associated with a restrictive diet in paediatrics, including impacts on nutrition and growth, disordered eating behaviours, psychosocial and family issues and families and the gut microbiome. The evidence suggests that the implementation of a dietary program is enhanced by a skilled dietitian when navigating a young person (and family) through healthy eating strategies and/or FODMAP restrictions to ameliorate their symptoms. Since the FODMAP diet is being prescribed globally to children, a practical guide for clinicians used to optimise efficacy and safety is provided, including the less restrictive 'FODMAP-gentle' diet.

Keywords: diet therapy; disordered eating; disorders of gut–brain interaction; irritable bowel syndrome; nutrition.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Diet, Carbohydrate-Restricted
  • Disaccharides
  • Fermentation
  • Humans
  • Irritable Bowel Syndrome*
  • Monosaccharides / adverse effects
  • Nutritional Status
  • Oligosaccharides
  • Pediatrics*

Substances

  • Monosaccharides
  • Disaccharides
  • Oligosaccharides

Grants and funding

This research received no external funding.